Arch Therapeutics Inc (ARTH)

[Snowy_Owl]

What I don’t understand is there are thousands of foot amputations annually due to wounds that don’t heal because of diabetes. Why didn’t at least a few Drs. try AC5 first? Had they dismissed it or weren’t they aware of it?

A couple years ago a diabetic co-worker had a below-the-knee amputation. Pain and suffering aside it was a tremendously expensive procedure. He told me the prosthetic alone cost more than the economy car he drove for his work commute. He said he would have tried almost anything if there was a chance of saving his leg and avoiding co-pay hell.

I believe a mature pharma with an established sales organization would see value in a product where most of the heavy lifting has been done.